> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Developing Covid Drugs/Biologics
- URL: https://www.fdaweb.com/guide-on-developing-covid-drugs-biologics/
- Published: 2021-05-11T12:00:00.000Z
- Updated: 2026-09-14T16:58:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149291

*Federal Register* notice: FDA is making available a final guidance entitled *Covid-19: Developing Drugs and Biological Products for Treatment or Prevention*. The document revises and replaces the final guidance of the same name issued on 5/11/2020\. Revisions were made to address the evolving landscape of Covid-19 drug development, including the emergence of SARS-CoV-2 variants and Covid vaccine availability. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-10061.pdf?ref=fdaweb.com).